Abeona Therapeutics Management
Management criteria checks 2/4
Abeona Therapeutics' CEO is Vish Seshadri, appointed in Oct 2021, has a tenure of 3.08 years. total yearly compensation is $2.85M, comprised of 19.5% salary and 80.5% bonuses, including company stock and options. directly owns 2.07% of the company’s shares, worth $5.79M. The average tenure of the management team and the board of directors is 3.1 years and 3.7 years respectively.
Key information
Vish Seshadri
Chief executive officer
US$2.8m
Total compensation
| CEO salary percentage | 19.5% |
| CEO tenure | 3.1yrs |
| CEO ownership | 2.1% |
| Management average tenure | 3.1yrs |
| Board average tenure | 3.7yrs |
Recent management updates
Recent updates
Is Abeona Therapeutics (NASDAQ:ABEO) Using Too Much Debt?
Sep 23
We're Not Very Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Rate
May 01We're Not Very Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Rate
Jan 04Here's Why We're Watching Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Situation
Aug 16Can Abeona Therapeutics (NASDAQ:ABEO) Afford To Invest In Growth?
Mar 31Abeona: Pivotal Data Readout EB-101 Before Year End Could Boost Shareholder Value
Oct 19Abeona Therapeutics stock continues recent strong run, shares rise ~10%
Oct 04Abeona Therapeutics GAAP EPS of -$2.08, revenue of $1M
Aug 11Abeona therapeutics regains compliance with Nasdaq minimum bid price requirement
Jul 20Abeona crashes 21% as reverse stock split takes effect
Jul 05Here's Why Abeona Therapeutics (NASDAQ:ABEO) Must Use Its Cash Wisely
Mar 02Here's Why Abeona Therapeutics (NASDAQ:ABEO) Can Manage Its Debt Despite Losing Money
Aug 17Abeona Therapeutics shares rise after letter to stockholders
May 26Despite Lacking Profits Abeona Therapeutics (NASDAQ:ABEO) Seems To Be On Top Of Its Debt
Apr 28Independent Director Paul Mann Just Sold A Bunch Of Shares In Abeona Therapeutics Inc. (NASDAQ:ABEO)
Feb 21How Much Did Abeona Therapeutics'(NASDAQ:ABEO) Shareholders Earn From Share Price Movements Over The Last Three Years?
Jan 19What Kind Of Investors Own Most Of Abeona Therapeutics Inc. (NASDAQ:ABEO)?
Dec 15
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$71m |
| Jun 30 2024 | n/a | n/a | -US$53m |
| Mar 31 2024 | n/a | n/a | -US$77m |
| Dec 31 2023 | US$3m | US$555k | -US$54m |
| Sep 30 2023 | n/a | n/a | -US$45m |
| Jun 30 2023 | n/a | n/a | -US$39m |
| Mar 31 2023 | n/a | n/a | -US$31m |
| Dec 31 2022 | US$1m | US$505k | -US$43m |
| Sep 30 2022 | n/a | n/a | -US$83m |
| Jun 30 2022 | n/a | n/a | -US$84m |
| Mar 31 2022 | n/a | n/a | -US$91m |
| Dec 31 2021 | US$2m | US$255k | -US$85m |
Compensation vs Market: Vish's total compensation ($USD2.85M) is above average for companies of similar size in the US market ($USD1.44M).
Compensation vs Earnings: Vish's compensation has increased whilst the company is unprofitable.
CEO
Vish Seshadri (48 yo)
3.1yrs
Tenure
US$2,847,442
Compensation
Dr. Vishwas Seshadri, also known as Vish, Ph.D. & M.B.A., serves as Chief Executive Officer, President and Director at Abeona Therapeutics Inc. since October 15, 2021. He served as the Senior Vice Presiden...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.1yrs | US$2.85m | 2.07% $ 5.8m | |
| Chief Financial Officer | 2.7yrs | US$1.49m | 0.84% $ 2.3m | |
| Senior VP & General Counsel | 4.6yrs | US$1.17m | 0.63% $ 1.8m | |
| Senior VP | 3.4yrs | no data | no data | |
| Vice President of Investor Relations & Corporate Communications | no data | no data | no data | |
| Chief People Officer | 2.8yrs | no data | no data | |
| VP & Head of Quality | 3.1yrs | no data | no data | |
| Senior VP | 1.2yrs | no data | no data | |
| Senior Vice President of Regulatory Affairs | no data | no data | no data |
3.1yrs
Average Tenure
51.5yo
Average Age
Experienced Management: ABEO's management team is considered experienced (3.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.1yrs | US$2.85m | 2.07% $ 5.8m | |
| Independent Director | 3.7yrs | US$336.14k | 0.17% $ 463.7k | |
| Independent Director | 3.7yrs | US$336.14k | 0.26% $ 729.0k | |
| Independent Director | 3.6yrs | US$330.52k | 0.26% $ 734.0k | |
| Independent Director | less than a year | no data | 0.025% $ 70.8k | |
| Independent Director | 4.7yrs | US$324.89k | 0.22% $ 624.8k | |
| Independent Director | 3.6yrs | US$336.14k | 0.27% $ 758.1k | |
| Member of Scientific Advisory Board | 7.6yrs | no data | no data | |
| Member of Scientific Advisory Board | 7.6yrs | no data | no data | |
| Member of Scientific Advisory Board | 7.6yrs | no data | no data | |
| Member of Scientific Advisory Board | 7.6yrs | no data | no data | |
| Chairman of the Board | 3.7yrs | US$351.14k | 0.33% $ 925.4k |
3.7yrs
Average Tenure
51yo
Average Age
Experienced Board: ABEO's board of directors are considered experienced (3.7 years average tenure).